发明名称 |
Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals |
摘要 |
Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions. |
申请公布号 |
US9119851(B2) |
申请公布日期 |
2015.09.01 |
申请号 |
US201414314802 |
申请日期 |
2014.06.25 |
申请人 |
NEUREN PHARMACEUTICALS, LTD. |
发明人 |
Bickerdike Michael John;Guan Jian |
分类号 |
A61K31/498;A61K31/4985;C07D487/04;C07D487/10 |
主分类号 |
A61K31/498 |
代理机构 |
Borson Law Group, PC |
代理人 |
Borson D. Benjamin;Borson Law Group, PC |
主权项 |
1. A method for relieving or alleviating a symptom of cognitive dysfunction caused by a disease, injury, or condition in a mammal in need thereof, comprising: administering a pharmaceutically effective amount of cyclic Glycyl-2-Allyl Proline (cG-2-AllylP) to said mammal thereby providing relief from the symptom, where said symptom is loss of spatial memory, loss of long-term memory, or loss of novelty recognition. |
地址 |
Auckland NZ |